Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Precancerous Conditions 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Tacrolimus 4Mycophenolic Acid 4Melphalan 4Busulfan 4Sulindac 3Methotrexate 3Biopsy 3Antilymphocyte Serum 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Mesna 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Etoposide 2Epoetin Alfa 2Eflornithine 2Cyclosporine 2Cetuximab 2Celecoxib 2vandetanib 1tanespimycin 1sintilimab 1perillyl alcohol 1antitumor A 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Precancerous Conditions × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00281736 2014-01-03

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
60 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡